Synthesis and Anticancer Properties of ‘Azole’ Based Chemotherapeutics as Emerging Chemical Moieties: A Comprehensive Review

Author(s): Parteek Prasher*, Mousmee Sharma, Flavia Zacconi, Gaurav Gupta, Alaa A.A. Aljabali, Vijay Mishra, Murtaza M. Tambuwala, Deepak N. Kapoor, Poonam Negi, Terezinha de Jesus Andreoli Pinto, Inderbir Singh, Dinesh K. Chellappan, Kamal Dua*

Journal Name: Current Organic Chemistry

Volume 25 , Issue 6 , 2021

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Azole frameworks serve as privileged scaffolds in the contemporary drug design paradigm owing to their unique physicochemical profile that promotes the development of highly selective, physiological benevolent chemotherapeutics. Several azole nuclei function as bioisostere in medicinal chemistry and prompt the development of tailored therapeutics for targeting the desired biological entities. Besides, the azole scaffold forms an integral part in the advanced drug designing methodologies, such as target template insitu drug synthesis, that assists in rapid identification of the hit molecules form a diverse pool of leads; and direct biomolecule-drug conjugation, along with bioorthogonal strategies that ensure localization, and superior target specificity of the directed therapeutic. Lastly, the structural diversity of azole framework and high yielding click synthetic methods provide a comprehensive Structure-Activity Relationship analysis for design optimization of the potential drug molecules by fine-tuning the placement of different substituents critical for the activity. This review provides a comprehensive analysis of the synthesis and anticancer potential of azole based chemotherapeutics.

Keywords: Azole, anticancer drugs, chemotherapeutics, molecular inhibitors, anticancer pathways, MAPK, TNF-α, NF-κB.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 20 August, 2020
Page: [654 - 668]
Pages: 15
DOI: 10.2174/1385272824999200820152501
Price: $65

Article Metrics

PDF: 32